Barclays’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $629K | Buy |
241,721
+122,990
| +104% | +$320K | ﹤0.01% | 2920 |
|
|
2025
Q1 | $226K | Sell |
118,731
-74,035
| -38% | -$141K | ﹤0.01% | 3266 |
|
|
2024
Q4 | $279K | Buy |
192,766
+22,521
| +13% | +$32.6K | ﹤0.01% | 3358 |
|
|
2024
Q3 | $314K | Buy |
170,245
+112,614
| +195% | +$208K | ﹤0.01% | 3251 |
|
|
2024
Q2 | $57K | Sell |
57,631
-18,282
| -24% | -$18.1K | ﹤0.01% | 3620 |
|
|
2024
Q1 | $150K | Sell |
75,913
-49,573
| -40% | -$98K | ﹤0.01% | 3474 |
|
|
2023
Q4 | $196K | Buy |
125,486
+95,183
| +314% | +$149K | ﹤0.01% | 3513 |
|
|
2023
Q3 | $59K | Sell |
30,303
-1,618
| -5% | -$3.15K | ﹤0.01% | 3527 |
|
|
2023
Q2 | $101K | Sell |
31,921
-9,065
| -22% | -$28.7K | ﹤0.01% | 3398 |
|
|
2023
Q1 | $134K | Buy |
40,986
+22,761
| +125% | +$74.4K | ﹤0.01% | 3373 |
|
|
2022
Q4 | $91K | Buy |
18,225
+17,851
| +4,773% | +$89.1K | ﹤0.01% | 3512 |
|
|
2022
Q3 | $1K | Buy |
+374
| New | +$1K | ﹤0.01% | 4550 |
|